Previous Page   Next Page

Learning Objectives

We aim to cover the following topics:

  1. The rationale for targeting DDR, including PARP inhibition as the proof of concept.
    • The mechanism of action of PARP inhibitors.
    • Role of diagnostics, and how diagnostics ensure appropriate patient selection.
  2. Current role of PARP inhibition in clinical practice, including:
    • The efficacy and safety/tolerability profile of PARP inhibitors.
    • The potential benefit of PARP inhibitors in various tumour types.
    • The appropriate patient selection for PARP inhibition.
    • The current indications for PARP inhibition in clinical practice.
  3. Anticipate the potential future application of targeting DDR in clinical practice, including
    • The potential combination strategies with PARP inhibitors.
    • The potential future role of targeting DDR in clinical practice, including drugs with a novel mode of action and their potential combination strategies.
    • The potential future indications for targeting DDR and PARP inhibition and the rationale for targeting DDR in these indications.
    • The potential future role of diagnostics in DDR.